Kimberly-Clark/$KMB

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Kimberly-Clark

With more than half of its sales from personal care and another third from consumer tissue products, Kimberly-Clark is a leading manufacturer in the tissue and hygiene realm. Its brand mix includes Huggies, PullUps, Kotex, Depend, Kleenex, and Cottonelle. The firm also operates in the professional segment, partnering with businesses to provide safety and sanitary offerings for the workplace. Kimberly-Clark generates just over half its sales in North America and more than 10% in Europe, with the rest primarily concentrated in Asia and Latin America.

Ticker

$KMB
Primary listing

Industry

Household Products

Employees

38,000

ISIN

US4943681035

Kimberly-Clark Metrics

BasicAdvanced
$43B
17.56
$7.34
0.39
$4.92
3.91%

What the Analysts think about Kimberly-Clark

Analyst ratings (Buy, Hold, Sell) for Kimberly-Clark stock.

Bulls say / Bears say

Kimberly-Clark's strategic focus on the growing adult incontinence market, with brands like Depend and Plenitud, positions the company to capitalize on demographic trends and a market projected to reach $20 billion by 2029. (ft.com)
The planned $3.5 billion sale of its international tissue business to Suzano allows Kimberly-Clark to streamline operations and focus on core, higher-margin segments, potentially enhancing profitability. (reuters.com)
Despite challenges, Kimberly-Clark reported a 1% organic sales growth in Q3 2024, driven by strong in-market execution and effective cost management, indicating resilience and operational efficiency. (kimberly-clark.com)
Kimberly-Clark lowered its 2025 profit forecast due to approximately $300 million in additional costs from new U.S. trade tariffs, highlighting vulnerability to geopolitical factors. (reuters.com)
In Q1 2025, the company reported a 6% decline in net sales to $4.84 billion and a 12.4% drop in net income, reflecting challenges in maintaining revenue and profitability. (industryintel.com)
The divestiture of its international tissue business, while streamlining operations, may reduce global market presence and expose the company to risks associated with over-reliance on specific segments. (ft.com)
Data summarised monthly by Lightyear AI. Last updated on 29 Jun 2025.

Kimberly-Clark Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Kimberly-Clark Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $KMB

Sign up or log in to buy
Capital at risk
Market open

Upcoming events

Jul2
Kimberly-Clark
Dividend·Payment
$1.26Per share
FAQs